The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

A new study suggests blockbuster weight loss drugs Wegovy and Zepbound are not cost-effective at their current prices, despite the proven health benefits. The study, published in JAMA Health Forum and ...

For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study ...

A surge of billion-dollar licensing deals in early 2025 is reinvigorating South Korea’s biotech industry, signaling renewed ...

Seen Health, an innovative health care provider transforming senior care, celebrated the grand opening of its first flagship Program of All-Inclusive Care for the Elderly (PACE) center in San Gabriel ...

Innovent and HUTCHMED received conditional approval for the combo in endometrial cancer from China’s NMPA last year.

“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week. (3/18) Here's today's health policy haiku: ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

During a health-focused event in New York on Tuesday, Google announced that it's developing a collection of "open" AI models ...

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”, the “Company” or “we”) ...

The tragic death of the 16-year-old boy came as a result of acute liver failure, which is a known side effect of Elevidys and ...